Maculopapular rash and tremor are associated with West Nile fever and neurological syndromes

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 78, Issue 5, 2007, Pages 529-531

  Tilley, Peter A G ^a   Fox, Julie D ^a   Jayaraman, Gayatri C ^b   Preiksaitis, Jutta K ^c  

^a UNIVERSITY OF CALGARY   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANADA; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; INFORMATION PROCESSING; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; TREMOR; VIRUS INFECTION; WEST NILE FLAVIVIRUS; MIDDLE AGED; RASH; RETROSPECTIVE STUDY; RISK FACTOR; SYNDROME;

IMMUNOGLOBULIN G; VIRUS RNA;

ADULT; ALBERTA; EXANTHEMA; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL; SYNDROME; TREMOR; WEST NILE FEVER;

EID: 34247182047     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2006.107862     Document Type: Article

References (12)

1. Pepperell C, Rau N, Krajden S, et al. West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. Can Med Assoc J 2003;168:1399-405.
2. Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999 [comment]. New Engl J Med 2001;344:1807-14.
3. Weiss D, Carr D, Kellachan J, et al. Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000. Emerg Infect Dis 2001;7:654-8.
4. Tilley PA, Walle R, Chow A, et al. Clinical utility of commercial enzyme immunoassays during the inaugural season of West Nile virus activity, Alberta, Canada. J Clin Microbiol 2005;43:4691-5.
5. Lanciotti RS, Kerst AJ. Nucleic acid sequence-based amplification assays for rapid detection of West Nile and St. Louis encephalitis viruses. J Clin Microbiol 2001;39:4506-13.
6. Tilley PA, Fox JD, Jayaraman GC, et al. Nucleic acid testing for west nile virus RNA in plasma enhances rapid diagnosis of acute infection in symptomatic patients. J Infect Dis 2006;193:1361-4.
7. Roehrig JT, Nash D, Maldin B, et al. Persistence of virus-reactive serum immunoglobulin m antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis 2003;9:376-9.
8. Sejvar JJ, Haddad MB, Tierney BC, et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA 2003;290:511-15.
9. Bosanko CM, Gilroy J, Wang AM, et al. West nile virus encephalitis involving the substantia nigra: neuroimaging and pathologic findings with literature review. Arch Neurol 2003;60:1448-52.
10. Rosas H, Wippold FJ2. West Nile virus: case report with MR imaging findings, Am J Neuroradiol 2003;24:1376-8.
11. Solomon T, Fisher AF, Beasley DW, et al. Natural and nosocomial infection in a patient with West Nile encephalitis and extrapyramidal movement disorders. Clin Infect Dis 2003;36:140-5.
12. Brilla R, Block M, Geremia G, et al. Clinical and neuroradiologic features of 39 consecutive cases of West Nile Virus meningoencephalitis. J Neurol Sci 2004;220:37-40.